GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Huadong Medicine Co Ltd (SZSE:000963) » Definitions » Cash Flow for Dividends

Huadong Medicine Co (SZSE:000963) Cash Flow for Dividends : ¥-579 Mil (TTM As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Huadong Medicine Co Cash Flow for Dividends?

Huadong Medicine Co's cash flow for dividends for the three months ended in Mar. 2024 was ¥-36 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-579 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Huadong Medicine Co's quarterly payment of dividends declined from Sep. 2023 (¥-38 Mil) to Dec. 2023 (¥49 Mil) but then increased from Dec. 2023 (¥49 Mil) to Mar. 2024 (¥-36 Mil).

Huadong Medicine Co's annual payment of dividends increased from Dec. 2021 (¥-460 Mil) to Dec. 2022 (¥-576 Mil) and increased from Dec. 2022 (¥-576 Mil) to Dec. 2023 (¥-594 Mil).

Huadong Medicine Co Cash Flow for Dividends Historical Data

The historical data trend for Huadong Medicine Co's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huadong Medicine Co Cash Flow for Dividends Chart

Huadong Medicine Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -570.63 -565.73 -460.11 -576.49 -594.22

Huadong Medicine Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -51.53 -553.76 -37.87 48.94 -36.43

Huadong Medicine Co Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-579 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Huadong Medicine Co Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Huadong Medicine Co's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Huadong Medicine Co (SZSE:000963) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Huadong Medicine Co Ltd (SZSE:000963) » Definitions » Cash Flow for Dividends
Comparable Companies
SHSE:600196 SHSE:600332 SZSE:002001 SZSE:000999 SHSE:600085 SZSE:000423 SZSE:000661 SHSE:688506 SHSE:600566 SHSE:600079 XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ NBIX SZSE:000538 NSE:DIVISLAB
Traded in Other Exchanges
N/A
Address
468 Yan’an Road, Floor 7, 9 and 10, Gate No. 1, Building No. 1, Hangzhou, CHN, 310006
Website
http://www.eastchinapharm.com
Huadong Medicine Co Ltd is engaged in the production and sales of antibiotics, proprietary Chinese medicine, chemical synthetic medicine and genetic engineering drugs products. It is also engaged in the wholesale, retail and distribution business of Chinese and western medicine, Chinese herbal medicine, medical apparatus, and instruments. The main business of the company is divided into pharmaceutical business sales and the industry of pharmaceutical. The product portfolio of the company includes Corbrin capsule, Cymusi, New Cyspin, Kasiping, Panlisu, Acarbose, and others.
Executives
He Ru Fen Supervisors
Hu Bao Zhen Supervisors
Zhou Shun Hua Executives
Shao Ling Min Supervisors
Wan Ling Ling Executives
Fu Hang Director
Yue Jin Director
Chen Bo Secretary Dong
Qin Yun Supervisors
Li Bang Liang Directors, executives
Zhou Jin Bao Directors, executives

Huadong Medicine Co (SZSE:000963) Headlines

No Headlines